FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

19476811000001102: Rapilose 40% gel (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Sep 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65832401000001112 Rapilose 40% gel (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65832501000001111 Rapilose 40% gel (Aspire Pharma Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
76580501000001117 Rapilose 40% gel (Galen Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapilose 40% gel (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Is a Glucose 40% oral gel true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has active ingredient Glucose true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has specific active ingredient Glucose true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has dispensed dose form Conventional release oral gel false Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Is a Rapilose true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has dispensed dose form Conventional release oral gel true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has AMP True Rapilose 40% gel (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start